Country: United States
Language: English
Source: NLM (National Library of Medicine)
ETHINYL ESTRADIOL (UNII: 423D2T571U) (ETHINYL ESTRADIOL - UNII:423D2T571U), NORETHINDRONE (UNII: T18F433X4S) (NORETHINDRONE - UNII:T18F433X4S)
Lupin Pharmaceuticals, Inc.
ETHINYL ESTRADIOL
ETHINYL ESTRADIOL 0.035 mg
PRESCRIPTION DRUG
Pirmella 7/7/7 and Pirmella 1/35 Tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and the NORPLANT® System depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. Source: Trussel J, Contraceptive efficacy. In Hatcher RA, Trussel J, Stewart F, Cates W, Stewart GK, Kowal D, Guest F, Contraceptive Technology: Seventeenth Revised Edition. New York NY: Irvington Publishers, 1998. Pirmella 7/7/7 and Pirmella 1/35 have not been studied for and are not indicated for use in emergency contraception. Oral contraceptives should not be used in women who currently have the following conditions: - Thrombophlebitis or thromboembolic dis
Pirmella 7/7/7 Tablets are available in a wallet (NDC 68180-892-11) containing 28 tablets. Such three wallets are packaged in a carton (NDC 68180-892-13). The wallet contains 28 tablets, as follows: Pirmella 1/35 Tablets are available in a wallet (NDC 68180-893-11) containing 28 tablets. Such three wallets are packaged in a carton (NDC 68180-893-13). The wallet contains 28 tablets, as follows: Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Abbreviated New Drug Application
PIRMELLA 7/7/7 - NORETHINDRONE AND ETHINYL ESTRADIOL PIRMELLA 1/35 - NORETHINDRONE AND ETHINYL ESTRADIOL LUPIN PHARMACEUTICALS, INC. ---------- PIRMELLA™ 7/7/7 AND PIRMELLA™ 1/35 TABLETS PIRMELLA™ 7/7/7 TABLETS (NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS USP) 0.5 MG/0.035 MG, 0.75 MG/0.035 MG AND 1 MG/0.035 MG AND PIRMELLA™ 1/35 TABLETS (NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS USP) 1 MG/0.035 MG RX ONLY WARNING: CARDIOVASCULAR RISK ASSOCIATED WITH SMOKING Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, combination oral contraceptives, including Pirmella, should not be used by women who are over 35 years of age and smoke. PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. COMBINED ORAL CONTRACEPTIVES Each of the following products is a combined oral contraceptive containing the progestational compound norethindrone and the estrogenic compound ethinyl estradiol. PIRMELLA™7/7/7 TABLETS: Each white tablet contains 0.5 mg of norethindrone and 0.035 mg of ethinyl estradiol. Inactive ingredients include lactose anhydrous, magnesium stearate and pregelatinized starch. Each light peach tablet contains 0.75 mg of norethindrone and 0.035 mg of ethinyl estradiol. Inactive ingredients include FD&C Yellow No. 6, lactose anhydrous, magnesium stearate and pregelatinized starch. Each peach tablet contains 1 mg of norethindrone and 0.035 mg of ethinyl estradiol. Inactive ingredients include FD&C Yellow No. 6, lactose anhydrous, magnesium stearate and pregelatinized starch. Each green tablet contains only inert ingredients, as follows: D&C Yellow No. 10, FD&C Blue No. 2, lactose monohydrate, magnesium stearate, microcrystalline cellulose and pregelatinized starch. PIRMELLA™1/35 TABLETS: Each peach tablet contains 1 mg of norethindrone and 0. Read the complete document